1. Celgene Corporation (28 from 549 patents)

2. Signal Pharmaceuticals, Inc. (10 from 169 patents)

3. Bristol-myers Squibb Compnay (1 from 3,681 patents)

1. 12486281 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith

2. 12404241 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

3. 12227490 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith

4. 12187699 - GSPT1 compounds and methods of use of the novel compounds

5. 12103920 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith

6. 12029738 - Antiproliferative compounds and methods of use thereof

7. 11945804 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

8. 11873283 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

9. 11739075 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith

10. 11726080 - Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

11. 11634407 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith

12. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

13. 11560371 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith

14. 11365184 - Antiproliferative compounds, and their pharmaceutical compositions and uses

15. 11358952 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith